Company intelligence / Profile preview

Portal Biotechnologies

Cambridge, Massachusetts, United Statesportal.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

Portal Biotechnologies Inc. is an active US-based biotech platform company that develops next-generation mechanical intracellular delivery systems designed for broad application across research and clinical settings.

Modalities: Intracellular delivery of siRNA, mRNA, saRNAProteins & peptidesCRISPR RNP complexesSmall moleculesAntibodiesViral vectorsNanoparticles and polymers also supported as cargoes
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Portal Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Portal Biotechnologies.

Explore the full profile